Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
European Journal of Clinical Pharmacology|February 25, 2017
No clinically meaningful pharmacokinetic interaction between the hepatitis C virus inhibitors elbasvir and grazoprevir and the oral contraceptives ethinyl estradiol and levonorgestrelWilliam L Marshall, Hwa-Ping Feng, Luzelena Caro, et al.
Hepatology (Baltimore, Md.)|April 5, 2012
Vaniprevir with pegylated interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C: a randomized phase II studyMichael P Manns, Edward Gane, Maribel Rodriguez-Torres, et al.
The Pediatric Infectious Disease Journal|January 19, 2024
Pharmacokinetics, Safety, and Efficacy of Letermovir for Cytomegalovirus Prophylaxis in Adolescent Hematopoietic Cell Transplantation RecipientsAndreas H Groll, Johannes H Schulte, Ali Bülent Antmen, et al.
Clinical and Translational Science|May 4, 2022
A phase I study to evaluate safety, pharmacokinetics, and pharmacodynamics of respiratory syncytial virus neutralizing monoclonal antibody MK-1654 in healthy Japanese adultsYuji Orito, Naoyuki Otani, Yuki Matsumoto, et al.
Clinical and Translational Science|November 12, 2025
Characterization of Drug-Drug Interactions for Remdesivir, an Intravenous Antiviral for SARS-CoV-2, in Healthy ParticipantsJack Chang, Aryun Kim, Rita Humeniuk, et al.
Clinical Drug Investigation|February 2, 2021
Evaluation of Pharmacokinetic Drug Interactions of the Direct-Acting Antiviral Agents Elbasvir and Grazoprevir with Pitavastatin, Rosuvastatin, Pravastatin, and Atorvastatin in Healthy AdultsLuzelena Caro, Thomayant Prueksaritanont, Christine M Fandozzi, et al.
Clinical Pharmacology : Advances and Applications|February 28, 2020
A Single- and Multiple-Dose Study to Evaluate the Pharmacokinetics of Fixed-Dose Grazoprevir/Elbasvir in Healthy Chinese ParticipantsHaiyan Li, Zhenhua Yang, Shuang Zhang, et al.
Clinical Pharmacology and Therapeutics|January 31, 2025
Clinical Evaluation of Drug-Drug Interactions with Obeldesivir, an Orally Administered Antiviral AgentChi-Chi Peng, Rita Humeniuk, Anuja Raut, et al.
British Journal of Clinical Pharmacology|March 13, 2014
Pitavastatin is a more sensitive and selective organic anion-transporting polypeptide 1B clinical probe than rosuvastatinThomayant Prueksaritanont, Xiaoyan Chu, Raymond Evers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 2014
Virologic resistance analysis from a phase 2 study of MK-5172 combined with pegylated interferon/ribavirin in treatment-naive patients with hepatitis C virus genotype 1 infectionAnita Y M Howe, Stuart Black, Stephanie Curry, et al.
Pageof 6